Impacts of social determinants of health on chronic opioid therapy for chronic non-cancer pain

被引:0
作者
Chen, Minghui [1 ,2 ]
Li, Tao [3 ]
机构
[1] Good Samaritan Reg Med Ctr, Dept Internal Med, Corvallis, OR 97330 USA
[2] Boston Med Ctr, Dept Anesthesiol, Boston, MA 02118 USA
[3] Oregon State Univ, Coll Hlth, Hlth Management & Policy, Corvallis, OR 97331 USA
关键词
chronic pain; electronic health records; financial difficulty; opioid therapy; patient-centered care; social determinants of health; DISCONTINUATION; RATES;
D O I
10.1080/17581869.2024.2366145
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim: We aimed to investigate the association between social determinants of health and chronic opioid therapy. Materials & methods: We conducted a retrospective analysis of electronic health records from five family medicine and internal medicine clinics in Oregon in 2020 and 2021. Our outcome variable was whether a patient was receiving chronic opioid therapy for chronic non-cancer pain. Our variables of interest included financial difficulty, insurance types, transportation barriers, currently married or living with a partner and organizations participation. Results: Our results showed that patients with financial difficulty were more likely to have chronic opioid therapy (OR: 2.69; 95% CI: 1.14, 6.33). Conclusion: Addressing patients' social determinants of health disadvantages is important for optimizing pain management.
引用
收藏
页码:251 / 257
页数:7
相关论文
共 32 条
[1]  
Ahmad FB., 2023, NATL HLTH STAT REPOR
[2]  
[Anonymous], 2022, Fact Sheet: White House Releases First-Ever Comprehensive Framework for Responsible Development of Digital Assets
[3]  
[Anonymous], 2023, The Helping to End Addiction Long-term Initiative Internet
[4]  
[Anonymous], 2019, Pain Management Best Practices Inter-Agency Task Force Report: Updates, Gaps, Inconsistencies, and Recommendations
[5]  
[Anonymous], HLTH PEOPLE 2030
[6]  
[Anonymous], 2014, Capturing social and behavioral domains in electronic health records: Phase 2
[7]  
[Anonymous], Stata Multiple-Imputation
[8]  
[Anonymous], CMS cell size suppression policy
[9]  
Baldini Angee, 2012, Prim Care Companion CNS Disord, V14, DOI 10.4088/PCC.11m01326
[10]  
Bonakdar Robert, 2019, Glob Adv Health Med, V8, p2164956119855629, DOI [10.1177/2164956119855629, 10.1177/2164956119855629]